--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--------
--------
MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
ORKA Oruka Therapeutics
- 20.310
- -0.450-2.17%
Close Dec 20 16:00 ET
- 20.310
- 0.0000.00%
Post 16:03 ET
710.82MMarket Cap-53.45P/E (TTM)
21.580High19.840Low2.54MVolume20.310Open20.760Pre Close51.87MTurnover10.86%Turnover RatioLossP/E (Static)35.00MShares33.00052wk High2.09P/B475.37MFloat Cap10.06852wk Low--Dividend TTM23.41MShs Float40838092.445Historical High--Div YieldTTM8.38%Amplitude10.068Historical Low20.402Avg Price1Lot Size
Oruka Therapeutics Key Stats
Oruka Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Oruka Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data